The company's testosterone gel 1.62 per cent, which is a therapeutic
equivalent generic version of AndroGel 1.62 per cent of AbbVie Inc,
was approved USFDA.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-launches-generic-testosterone-gel-in-us-market/articleshow/69198308.cms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment